-
High levels of global hydroxymethylation predict worse overall survival in MDS patients treated with azacitidine
Tiso, F., in 't Hout, F. E. M., Knops, R., Kroeze, L. I., van Rooij, A., van de Loosdrecht, A. A., Westers, T. M., Langemeijer, S. M. C., Preudhomme, C., Duployez, N., Fenaux, P., Kosmider, O., Bouscary, D., de Graaf, A. O., Martens, J. H. A., van der Reijden, B. A., Adès, L., Fontenay, M. & Jansen, J. H., 1 Jan 2025, In: HemaSphere. 9, 1, e70034.Research output: Contribution to journal › Comment/Letter to the editor* › Academic
-
Expression levels of genes implicated in the working mechanism of lenalidomide predict treatment response in lower risk myelodysplastic syndrome patients
In 't Hout, F. E. M., Scheele, T. N., Westers, T. M., Alhan, C., Duetz, C., Cremers, E. M. P., Visser-Wisselaar, H. A., Verbrugge, A., Chitu, D. A., Van der Reijden, B. A., De Graaf, A. O., Jansen, J. H. & van de Loosdrecht, A. A., 10 Oct 2024, (E-pub ahead of print) In: Haematologica.Research output: Contribution to journal › Article* › Academic › peer-review
-
The role of the primitive marker CD133 in CD34-negative acute myeloid leukemia for the detection of leukemia stem cells
Reuvekamp, T., Janssen, L. L. G., Ngai, L. L., Carbaat-Ham, J., den Hartog, D., Scholten, W. J., Kelder, A., Hanekamp, D., Wensink, E., van Gils, N., Gradowska, P., Löwenberg, B., Ossenkoppele, G. J., van de Loosdrecht, A. A., Westers, T. M., Smit, L., Bachas, C. & Cloos, J., 23 Aug 2024, (E-pub ahead of print) In: Cytometry. Part B, Clinical cytometry.Research output: Contribution to journal › Article* › Academic › peer-review
- All publications
